[HTML][HTML] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 omicron infection in healthcare workers: a …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - …, 2024 - thelancet.com
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
[HTML][HTML] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren… - …, 2024 - ncbi.nlm.nih.gov
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
[HTML][HTML] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - eClinicalMedicine, 2024 - Elsevier
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
[PDF][PDF] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - 2023 - scienceopen.com
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
[HTML][HTML] Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - …, 2024 - thelancet.com
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective …
H Mi, Q Chen, H Lin, T He, R Zhang… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - …, 2023 - europepmc.org
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
Short-term effectiveness of single-dose intranasal spray COVID-19 vaccine against symptomatic SARS-CoV-2 Omicron infection in healthcare workers: a prospective …
H Mi, Q Chen, H Lin, T He, R Zhang, S Ren, L Liu… - …, 2023 - europepmc.org
Background The pivotal phase 3 efficacy clinical trial has demonstrated that a two-dose
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …
regimen of dNS1-RBD (Beijing Wantai Biological Pharmacy Enterprise, Beijing, China) is …